Search Results - "MALABARBA, Lucia"
-
1
Unbalanced X‐chromosome inactivation in haemopoietic cells from normal women
Published in British journal of haematology (01-09-1998)“…We studied X‐chromosome inactivation patterns in blood cells from normal females in three age groups: neonates (umbilical cord blood), 25–32 years old (young…”
Get full text
Journal Article -
2
Plerixafor on demand in ten healthy family donors as a rescue strategy to achieve an adequate graft for stem cell transplantation
Published in Transfusion (Philadelphia, Pa.) (01-08-2015)“…BACKGROUND In allogeneic hematopoietic stem cell (HSC) transplantation, the collection of an appropriate number of HSCs while maintaining a high level of…”
Get full text
Journal Article -
3
Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia
Published in The American journal of medicine (15-11-2004)“…To assess life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia. The study sample consisted of…”
Get more information
Journal Article -
4
Chlamydophila psittaci is viable and infectious in the conjunctiva and peripheral blood of patients with ocular adnexal lymphoma: Results of a single‐center prospective case–control study
Published in International journal of cancer (01-09-2008)“…Ocular adnexal MALT lymphoma (OAML) is linked to Chlamydophila psittaci (Cp) infection. Viability and infectivity of Cp, demonstrated by growth in culture, has…”
Get full text
Journal Article -
5
Standardized Long-Term Follow-up after Allogeneic Stem Cell Transplantation: A Cross-Sectional 1-Year Evaluation in 260 Adults
Published in Blood (03-12-2015)“…▪ Introduction Allogeneic hematopoietic cell transplantation (HCT) is an effective therapeutic option for high-risk hematological malignancies; 80% of those…”
Get full text
Journal Article -
6
Clinical utility of the absolute number of circulating CD34-positive cells in patients with chronic myeloproliferative disorders
Published in Haematologica (Roma) (01-10-2003)“…Division of Hematology, University of Pavia Medical School & IRCCS Policlinico S. Matteo, Pavia, Italy. BACKGROUND AND OBJECTIVES: Flow cytometry enumeration…”
Get full text
Journal Article -
7
Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia
Published in Haematologica (Roma) (01-01-2003)“…Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Italy f.passamonti@smatteo.pv.it BACKGROUND AND OBJECTIVES: Polycythemia vera (PV)…”
Get full text
Journal Article -
8
Clinical significance of neutrophil CD177 mRNA expression in Ph‐negative chronic myeloproliferative disorders
Published in British journal of haematology (01-09-2004)“…Summary The PRV‐1 gene has been proposed as a marker of polycythaemia vera (PV). PRV‐1 and NB1 are alleles of the polymorphic gene CD177, which belongs to the…”
Get full text
Journal Article -
9
Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to the WHO Criteria. A Basis for Clinical Decision-Making
Published in Blood (16-11-2004)“…The WHO recently proposed a new classification of myelodysplastic syndromes (MDS) based on uni- or multi-lineage hematopoietic involvement, blast count and…”
Get full text
Journal Article -
10
Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis
Published in British journal of haematology (01-03-2002)“…Essential thrombocythaemia (ET) is a disease associated with an elevated risk of thrombosis. This study evaluated the efficacy and safety of pipobroman (PB) in…”
Get full text
Journal Article -
11
Evidence of Polyclonal Hematopoiesis in a Large Proportion of Patients with Low-Risk Myelodysplastic Syndrome
Published in Blood (16-11-2004)“…Myelodysplastic syndromes (MDS) are usually defined as clonal proliferations of pluripotent stem cells, which retain their capacity to differentiate but do so…”
Get full text
Journal Article -
12
Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman
Published in Annals of hematology (01-08-2004)Get full text
Journal Article -
13
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes
Published in British journal of haematology (01-07-2002)“…We treated six patients with primary myelodysplastic syndrome (MDS) with amifostine (200 mg/m2 i.v./three times a week for three consecutive weeks). Neutrophil…”
Get full text
Journal Article -
14
Cord blood-derived hematopoietic progenitor cells : in vitro response to hematopoietic growth factors and their recruitment into the S-phase of the cell cycle
Published in Haematologica (Roma) (01-11-2000)“…In the recent years many studies on the expansion of cord blood (CB)-derived progenitor cells have been performed, whereas less information is available on…”
Get full text
Conference Proceeding Journal Article